Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.

Detalles Bibliográficos
Publicado en:Clinical Infectious Diseases Vol. 72; no. 10; pp. 1823 - 1826
Autor principal: Morse, Gene D
Formato: commentary editorial tables/charts Journal Article
Publicado: Oxford University Press / USA 5/15/2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150407125&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150407125
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10584838
        46X
      jtl: Clinical Infectious Diseases
      issn: 10584838
      maglogo: N
    pubinfo:
      dt: 5/15/2021
      vid: 72
      iid: 10
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        150407125
        150407125
        150407125
        10.1093/cid/ciaa982
        150407125
      ppf: 1823
      ppct: 3
      formats:
      tig:
        atl: Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.
      aug:
        au: Morse, Gene D
        affil: University at Buffalo , Buffalo, New York , USA
      sug:
        subj:
          Drug Interactions
          Implementation Science
          Research Methodology
          Efavirenz Pharmacokinetics
          Drug Resistance
      pubtype: Academic Journal
      doctype:
        commentary
        editorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N